Original Research Article
Year: 2018 | Month: September | Volume: 5 | Issue: 9 | Pages: 1-4
Cost Variation Analysis of Oral Hypolipidemic Drugs Available In Indian Market
Adnan Lakdawala
MIMER Medical College, Talegaon Dabhade, Pune-410507
ABSTRACT
Background: In a developing country, drug pricing plays a very important role. Due to the availability of different brands of the same drug, a wide price variation exists. Hence this study was planned to find out variation in prices of oral hypolipidemic drugs marketed in India.
Objective: To compare the percentage price variation and cost ratio of various formulations of oral hypolipidemic drugs available in the Indian market.
Methods: Cost of oral hypolipidemic drugs available in the Indian market manufactured by different companies, in the same strength, number and dosage form was obtained from http://www.medguideindia.com. The percentage price variation and cost ratio of each formulation was calculated.
Result: Tab Rosuvastatin 10mg shows maximum price variation of 3233% and a cost ratio of 33.33 followed by Tab Atorvastatin 10mg having a price variation of 1592.85 % and a cost ratio of 16.33. Tab Fenofibrate 67mg shows minimum price variation of 13 % with a cost ratio of 1.13. Highest numbers of brands are for Tab Atorvastatin 10mg (283) followed by Tab Atorvastatin 20mg (191)
Conclusion: There is a huge price variation between the minimum and maximum cost among the different brands of the same drug. Government, pharmaceutical companies, regulatory authorities, physicians and pharmacist need to work together towards controlling the drug pricing and helping the patients in attaining economic benefits.
Key words: Cost variation, oral hypolipidemic, Pharmacoeconomic
[PDF Full Text]